Clinical Trials Browser

OTHER_GOV × Lymphoma, Non-Hodgkin × zanubrutinib × Clear all

NCT06427213 2024-05-23

This is a Phase II, Open-label, Multicentre Study of Zanubrutinib-containing Regimens in Patients With Newly Diagnosed Mantle Cell Lymphoma

Phase 2 Not yet recruiting

Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell